Annals of Behavioral Medicine

, Volume 50, Issue 5, pp 762–774 | Cite as

A Randomized Controlled Trial to Prevent Depression and Ameliorate Insulin Resistance in Adolescent Girls at Risk for Type 2 Diabetes

  • Lauren B. Shomaker
  • Nichole R. Kelly
  • Courtney K. Pickworth
  • Omni L. Cassidy
  • Rachel M. Radin
  • Lisa M. Shank
  • Anna Vannucci
  • Katherine A. Thompson
  • Sara A. Armaiz-Flores
  • Sheila M. Brady
  • Andrew P. Demidowich
  • Ovidiu A. Galescu
  • Amber B. Courville
  • Cara Olsen
  • Kong Y. Chen
  • Eric Stice
  • Marian Tanofsky-Kraff
  • Jack A. Yanovski
Original Article

Abstract

Background

Prospective data suggest depressive symptoms worsen insulin resistance and accelerate type 2 diabetes (T2D) onset.

Purpose

We sought to determine whether reducing depressive symptoms in overweight/obese adolescents at risk for T2D would increase insulin sensitivity and mitigate T2D risk.

Method

We conducted a parallel-group, randomized controlled trial comparing a 6-week cognitive–behavioral (CB) depression prevention group with a 6-week health education (HE) control group in 119 overweight/obese adolescent girls with mild-to-moderate depressive symptoms (Center for Epidemiological Studies—Depression Scale [CES-D] ≥16) and T2D family history. Primary outcomes were baseline to post-intervention changes in CES-D and whole body insulin sensitivity index (WBISI), derived from 2-h oral glucose tolerance tests. Outcome changes were compared between groups using ANCOVA, adjusting for respective baseline outcome, puberty, race, facilitator, T2D family history degree, baseline age, adiposity, and adiposity change. Multiple imputation was used for missing data.

Results

Depressive symptoms decreased (p < 0.001) in CB and HE from baseline to posttreatment, but did not differ between groups (ΔCESD = −12 vs. −11, 95 % CI difference = −4 to +1, p = 0.31). Insulin sensitivity was stable (p > 0.29) in CB and HE (ΔWBISI = 0.1 vs. 0.2, 95 % CI difference = −0.6 to +0.4, p = 0.63). Among all participants, reductions in depressive symptoms were associated with improvements in insulin sensitivity (p = 0.02).

Conclusions

Girls at risk for T2D displayed reduced depressive symptoms following 6 weeks of CB or HE. Decreases in depressive symptoms related to improvements in insulin sensitivity. Longer-term follow-up is needed to determine whether either program causes sustained decreases in depressive symptoms and improvements in insulin sensitivity.

Trial Registration Number

The trial was registered with clinicaltrials.gov (NCT01425905).

Keywords

Adolescence Depression Insulin resistance Type 2 diabetes Randomized controlled trial 

Notes

Acknowledgments

This study was supported by K99HD069516 and R00HD069516 (L.B.S.) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH) Intramural Research Program grant 1ZIAHD000641 (J.A.Y.) from NICHD with supplemental funding from the NIH Bench to Bedside Program (L.B.S., M.T., J.A.Y.), Office of Behavioral and Social Sciences Research (J.A.Y.), and the NIH Office of Disease Prevention (J.A.Y.). C.K.P. was supported by a training award from the NIH Office of the Director. S.A.A. was supported by the NIH Medical Research Scholars Program, a public–private partnership supported jointly by the NIH and generous contributions to the Foundation for the NIH from Pfizer Inc., The Doris Duke Charitable Foundation, The Newport Foundation, The American Association for Dental Research, The Howard Hughes Medical Institute, and the Colgate Palmolive Company, as well as other private donors. The authors acknowledge the assistance of Heather Shaw, Ph.D., Oregon Research Institute, for her help in rating intervention sessions for fidelity and leader competence.

Compliance with Ethical Standards

Conflict of Interest and Adherence to Ethical Standards

The material presented in this manuscript is original research. It has not been previously published, nor is it under review elsewhere. The research was carried out in compliance with the ethical standards of the American Psychological Association and the American Medical Association. None of the authors has a conflict of interest to disclose.

References

  1. 1.
    Forouhi NG, Wareham NJ. Epidemiology of diabetes. Med (Abingdon). 2014; 42: 698-702.Google Scholar
  2. 2.
    Gregg EW, Zhuo X, Cheng YJ, et al. Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985–2011: A modelling study. Lancet Diabetes Endocrinol. 2014; 2: 867-874.CrossRefPubMedGoogle Scholar
  3. 3.
    Dabelea D, Mayer-Davis EJ, Saydah S, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014; 311: 1778-1786.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Ducat L, Philipson LH, Anderson BJ. The mental health comorbidities of diabetes. JAMA. 2014; 312: 691-692.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care. 2001; 24: 1069-1078.CrossRefPubMedGoogle Scholar
  6. 6.
    Hood KK, Beavers DP, Yi-Frazier J, et al. Psychosocial burden and glycemic control during the first 6 years of diabetes: Results from the SEARCH for Diabetes in Youth Study. J Adolesc Health. 2014; 55: 498-504.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Semenkovich K, Brown ME, Svrakic DM, Lustman PJ. Depression in type 2 diabetes mellitus: Prevalence, impact, and treatment. Drugs. 2015; 75: 577-587.CrossRefPubMedGoogle Scholar
  8. 8.
    Yu M, Zhang X, Lu F, Fang L. Depression and risk for diabetes: A meta-analysis. Can J Diabetes. 2015; 39: 266-272.CrossRefPubMedGoogle Scholar
  9. 9.
    Morrison JA, Glueck CJ, Horn PS, Wang P. Childhood predictors of adult type 2 diabetes at 9- and 26-year follow-ups. Arch Pediatr Adolesc Med. 2010; 164: 53-60.CrossRefPubMedGoogle Scholar
  10. 10.
    Hannon TS, Li Z, Tu W, et al. Depressive symptoms are associated with fasting insulin resistance in obese youth. Pediatr Obes. 2014; 9: e103-107.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Hannon TS, Rofey DL, Lee S, Arslanian SA. Depressive symptoms and metabolic markers of risk for type 2 diabetes in obese adolescents. Pediatr Diabetes. 2013; 14: 497-503.CrossRefPubMedGoogle Scholar
  12. 12.
    Shomaker LB, Tanofsky-Kraff M, Young-Hyman D, et al. Psychological symptoms and insulin sensitivity in adolescents. Pediatr Diabetes. 2010; 11: 417-423.CrossRefPubMedGoogle Scholar
  13. 13.
    Jaser SS, Holl MG, Jefferson V, Grey M. Correlates of depressive symptoms in urban youth at risk for type 2 diabetes mellitus. J Sch Health. 2009; 79: 286-292.CrossRefPubMedGoogle Scholar
  14. 14.
    Shomaker LB, Tanofsky-Kraff M, Stern EA, et al. Longitudinal study of depressive symptoms and progression of insulin resistance in youth at risk for adult obesity. Diabetes Care. 2011; 34: 2458-2463.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Winokur A, Maislin G, Phillips JL, Amsterdam JD. Insulin resistance after oral glucose tolerance testing in patients with major depression. Am J Psychiatry. 1988; 145: 325-330.CrossRefPubMedGoogle Scholar
  16. 16.
    Okamura F, Tashiro A, Utumi A, et al. Insulin resistance in patients with depression and its changes during the clinical course of depression: Minimal model analysis. Metabolism. 2000; 49: 1255-1260.CrossRefPubMedGoogle Scholar
  17. 17.
    Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with diabetes mellitus: An abridged Cochrane review. Diabet Med. 2014; 31: 773-786.CrossRefPubMedGoogle Scholar
  18. 18.
    Stice E, Presnell K, Spangler D. Risk factors for binge eating onset in adolescent girls: A 2-year prospective investigation. Health Psychol. 2002; 21: 131-138.CrossRefPubMedGoogle Scholar
  19. 19.
    Shomaker LB, Tanofsky-Kraff M, Zocca JM, et al. Depressive symptoms and cardiorespiratory fitness in obese adolescents. J Adolesc Health. 2012; 50: 87-92.CrossRefPubMedGoogle Scholar
  20. 20.
    Jerstad SJ, Boutelle KN, Ness KK, Stice E. Prospective reciprocal relations between physical activity and depression in female adolescents. J Consult Clin Psychol. 2010; 78: 268-272.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Keenan K, Hipwell A, Babinski D, et al. Examining the developmental interface of cortisol and depression symptoms in young adolescent girls. Psychoneuroendocrinology. 2013; 38: 2291-2299.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Fisher JO, Cai G, Jaramillo SJ, et al. Heritability of hyperphagic eating behavior and appetite-related hormones among Hispanic children. Obesity (Silver Spring). 2007; 15: 1484-1495.CrossRefGoogle Scholar
  23. 23.
    Dwyer T, Magnussen CG, Schmidt MD, et al. Decline in physical fitness from childhood to adulthood associated with increased obesity and insulin resistance in adults. Diabetes Care. 2009; 32: 683-687.CrossRefPubMedGoogle Scholar
  24. 24.
    Reinehr T, Andler W. Cortisol and its relation to insulin resistance before and after weight loss in obese children. Horm Res. 2004; 62: 107-112.CrossRefPubMedGoogle Scholar
  25. 25.
    Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1977; 1: 385-401.CrossRefGoogle Scholar
  26. 26.
    Stice E, Rohde P, Seeley JR, Gau JM. Brief cognitive–behavioral depression prevention program outperforms two alternative interventions: A randomized efficacy trial. J Consult Clin Psychol. 2008; 76: 595-606.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Stice E, Rohde P, Gau JM, Wade E. Efficacy trial of a brief cognitive–behavioral depression prevention program for high-risk adolescents: Effects at 1- and 2-year follow-up. J Consult Clin Psychol. 2010; 78: 856-867.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Bravender T. Health, Education, and Youth in Durham: HEY-Durham Curricular Guide. 2nd ed. Durham, NC: Duke University; 2005.Google Scholar
  29. 29.
    Tanofsky-Kraff M, Shomaker LB, Wilfley DE, et al. Targeted prevention of excess weight gain and eating disorders in high-risk adolescent girls: A randomized controlled trial. Am J Clin Nutr. 2014; 100: 1010-1018.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Tanofsky-Kraff M, Wilfley DE, Young JF, et al. A pilot study of interpersonal psychotherapy for preventing excess weight gain in adolescent girls at-risk for obesity. Int J Eat Disord. 2010; 43: 701-706.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969; 44: 291-303.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Kaufman J, Birmaher B, Brent D, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children—Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997; 36: 980-988.CrossRefPubMedGoogle Scholar
  33. 33.
    Nolen-Hoeksema S, Stice E, Wade E, Bohon C. Reciprocal relations between rumination and bulimic, substance abuse, and depressive symptoms in female adolescents. J Abnorm Psychol. 2007; 116: 198-207.CrossRefPubMedGoogle Scholar
  34. 34.
    Yeckel CW, Weiss R, Dziura J, et al. Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab. 2004; 89: 1096-1101.CrossRefPubMedGoogle Scholar
  35. 35.
    Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-419.CrossRefPubMedGoogle Scholar
  36. 36.
    Shomaker LB, Tanofsky-Kraff M, Zocca JM, et al. Eating in the absence of hunger in adolescents: Intake after a large-array meal compared with that after a standardized meal. Am J Clin Nutr. 2010; 92: 697-703.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Drinkard B, McDuffie J, McCann S, et al. Relationships between walk/run performance and cardiorespiratory fitness in adolescents who are overweight. Phys Ther. 2001; 81: 1889-1896.PubMedGoogle Scholar
  38. 38.
    von Baeyer CL, Piira T, Chambers CT, Trapanotto M, Zeltzer LK. Guidelines for the cold pressor task as an experimental pain stimulus for use with children. J Pain. 2005; 6: 218-227.CrossRefGoogle Scholar
  39. 39.
    Stice E, Shaw H, Bohon C, Marti CN, Rohde P. A meta-analytic review of depression prevention programs for children and adolescents: Factors that predict magnitude of intervention effects. J Consult Clin Psychol. 2009; 77: 486-503.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Radikova Z, Koska J, Huckova M, et al. Insulin sensitivity indices: A proposal of cut-off points for simple identification of insulin-resistant subjects. Exp Clin Endocrinol Diabetes. 2006; 114: 249-256.CrossRefPubMedGoogle Scholar
  41. 41.
    Libman IM, Barinas-Mitchell E, Bartucci A, et al. Fasting and 2-hour plasma glucose and insulin: Relationship with risk factors for cardiovascular disease in overweight nondiabetic children. Diabetes Care. 2010; 33: 2674-2676.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Stockings E, Degenhardt L, Lee YY, et al. Symptom screening scales for detecting major depressive disorder in children and adolescents: A systematic review and meta-analysis of reliability, validity and diagnostic utility. J Affect Disord. 2015; 174: 447-463.CrossRefPubMedGoogle Scholar
  43. 43.
    Goran MI, Shaibi GQ, Weigensberg MJ, Davis JN, Cruz ML. Deterioration of insulin sensitivity and beta-cell function in overweight Hispanic children during pubertal transition: A longitudinal assessment. Int J Pediatr Obes. 2006; 1: 139-145.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Savoye M, Caprio S, Dziura J, et al. Reversal of early abnormalities in glucose metabolism in obese youth: Results of an intensive lifestyle randomized controlled trial. Diabetes Care. 2014; 37: 317-324.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Holt RI, de Groot M, Golden SH. Diabetes and depression. Curr Diabetes Rep. 2014; 14: 491.CrossRefGoogle Scholar
  46. 46.
    Calhoun CD, Franklin JC, Adelman CB, et al. Biological and cognitive responses to an in vivo interpersonal stressor: Longitudinal associations with adolescent depression. Int J Cogn Ther. 2012; 5: 283-299.CrossRefGoogle Scholar
  47. 47.
    Lamers F, Vogelzangs N, Merikangas KR, et al. Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry. 2013; 18: 692-699.CrossRefPubMedGoogle Scholar
  48. 48.
    Safren SA, Gonzalez JS, Wexler DJ, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Diabetes Care. 2014; 37: 625-633.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Society of Behavioral Medicine 2016

Authors and Affiliations

  • Lauren B. Shomaker
    • 1
    • 2
    • 3
  • Nichole R. Kelly
    • 1
    • 2
    • 3
  • Courtney K. Pickworth
    • 1
  • Omni L. Cassidy
    • 1
    • 2
  • Rachel M. Radin
    • 1
    • 2
  • Lisa M. Shank
    • 1
    • 2
  • Anna Vannucci
    • 1
    • 2
  • Katherine A. Thompson
    • 1
  • Sara A. Armaiz-Flores
    • 1
  • Sheila M. Brady
    • 1
  • Andrew P. Demidowich
    • 1
  • Ovidiu A. Galescu
    • 1
  • Amber B. Courville
    • 4
  • Cara Olsen
    • 5
  • Kong Y. Chen
    • 6
  • Eric Stice
    • 7
  • Marian Tanofsky-Kraff
    • 1
    • 2
  • Jack A. Yanovski
    • 1
  1. 1.Section on Growth and Obesity, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)National Institutes of Health (NIH), Hatfield Clinical Research CenterBethesdaUSA
  2. 2.Department of Medical and Clinical PsychologyUniformed Services University of the Health Sciences (USUHS)BethesdaUSA
  3. 3.Department of Human Development and Family Studies and Colorado School of Public HealthColorado State UniversityFort CollinsUSA
  4. 4.Nutrition DepartmentMark O. Hatfield Clinical Center, NIHBethesdaUSA
  5. 5.Biostatistics, Department of Preventive MedicineUniformed Services University of the Health SciencesBethesdaUSA
  6. 6.Diabetes, Endocrinology, and Obesity BranchNational Institute of Diabetes, Digestive and Kidney Diseases, NIHBethesdaUSA
  7. 7.Oregon Research InstituteEugeneUSA

Personalised recommendations